Buy Adverum Biotechnologies Stock | ADVM Stock Price & Latest News | Public
ADVM

Adverum Biotechnologies

$0.00 (0.00%)Today

    About ADVM

    Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitry...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.12
    -0.24
    -0.36
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.32

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,11B
    Volume18,22k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$26.98
    1 Year Low$7.36
    Open$13.90
    High$14.25
    Low$13.85

    Buy any stock with any amount of money.

    Download the App
    Download the app